Hassan MM - Search Results

1

Vascular endothelial growth factor in the management of hepatocellular carcinoma: a review of literature.

Kaseb AO, Hanbali A, Cotant M, Hassan MM, Wollner I, Philip PA. Kaseb AO, et al. Among authors: hassan mm. Cancer. 2009 Nov 1;115(21):4895-906. doi: 10.1002/cncr.24537. Cancer. 2009. PMID: 19637355 Free article. Review.

2

Mutagen sensitivity as a susceptibility marker for human hepatocellular carcinoma.

Wu X, Gu J, Patt Y, Hassan M, Spitz MR, Beasley RP, Hwang LY. Wu X, et al. Cancer Epidemiol Biomarkers Prev. 1998 Jul;7(7):567-70. Cancer Epidemiol Biomarkers Prev. 1998. PMID: 9681523

3

Durable clinical response of refractory hepatocellular carcinoma to orally administered thalidomide.

Patt YZ, Hassan MM, Lozano RD, Ellis LM, Peterson JA, Waugh KA. Patt YZ, et al. Among authors: hassan mm. Am J Clin Oncol. 2000 Jun;23(3):319-21. doi: 10.1097/00000421-200006000-00023. Am J Clin Oncol. 2000. PMID: 10857902

4

The role of hepatitis C in hepatocellular carcinoma: a case control study among Egyptian patients.

Hassan MM, Zaghloul AS, El-Serag HB, Soliman O, Patt YZ, Chappell CL, Beasley RP, Hwang LY. Hassan MM, et al. J Clin Gastroenterol. 2001 Aug;33(2):123-6. doi: 10.1097/00004836-200108000-00006. J Clin Gastroenterol. 2001. PMID: 11468438

5

Rising prevalence of hepatitis C virus infection among patients recently diagnosed with hepatocellular carcinoma in the United States.

Hassan MM, Frome A, Patt YZ, El-Serag HB. Hassan MM, et al. J Clin Gastroenterol. 2002 Sep;35(3):266-9. doi: 10.1097/00004836-200209000-00013. J Clin Gastroenterol. 2002. PMID: 12192205

6

Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus.

Hassan MM, Hwang LY, Hatten CJ, Swaim M, Li D, Abbruzzese JL, Beasley P, Patt YZ. Hassan MM, et al. Hepatology. 2002 Nov;36(5):1206-13. doi: 10.1053/jhep.2002.36780. Hepatology. 2002. PMID: 12395331

7

Association between expression of transcription factor Sp1 and increased vascular endothelial growth factor expression, advanced stage, and poor survival in patients with resected gastric cancer.

Yao JC, Wang L, Wei D, Gong W, Hassan M, Wu TT, Mansfield P, Ajani J, Xie K. Yao JC, et al. Clin Cancer Res. 2004 Jun 15;10(12 Pt 1):4109-17. doi: 10.1158/1078-0432.CCR-03-0628. Clin Cancer Res. 2004. PMID: 15217947

8

Oral capecitabine for the treatment of hepatocellular carcinoma, cholangiocarcinoma, and gallbladder carcinoma.

Patt YZ, Hassan MM, Aguayo A, Nooka AK, Lozano RD, Curley SA, Vauthey JN, Ellis LM, Schnirer II, Wolff RA, Charnsangavej C, Brown TD. Patt YZ, et al. Among authors: hassan mm. Cancer. 2004 Aug 1;101(3):578-86. doi: 10.1002/cncr.20368. Cancer. 2004. PMID: 15274071 Free article.

9

Thalidomide in the treatment of patients with hepatocellular carcinoma: a phase II trial.

Patt YZ, Hassan MM, Lozano RD, Nooka AK, Schnirer II, Zeldis JB, Abbruzzese JL, Brown TD. Patt YZ, et al. Among authors: hassan mm. Cancer. 2005 Feb 15;103(4):749-55. doi: 10.1002/cncr.20821. Cancer. 2005. PMID: 15660400 Free article. Clinical Trial.

10

Significant effect of homologous recombination DNA repair gene polymorphisms on pancreatic cancer survival.

Li D, Liu H, Jiao L, Chang DZ, Beinart G, Wolff RA, Evans DB, Hassan MM, Abbruzzese JL. Li D, et al. Among authors: hassan mm. Cancer Res. 2006 Mar 15;66(6):3323-30. doi: 10.1158/0008-5472.CAN-05-3032. Cancer Res. 2006. PMID: 16540687 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

773 results

Search Page

Filters